NASDAQ:SGMT 27 April 2026

Sagimet Stock Surges as $175 Million Raise Sharpens Acne Drug Push

Sagimet Biosciences priced 29.17 million shares at $6 each, seeking to raise $175 million to fund a U.S. Phase 3 acne trial for denifanstat. Shares rose 38% to $8.12 on heavy volume Monday. The company will delay further work on its MASH liver-disease program unless it secures non-dilutive funding. Sagimet reported about $104.5 million in cash and equivalents.

27 April 2026

NASDAQ:SGMT·Pharmaceuticals·Stock Market

Kyoto Financial Group (TSE:5844) Stock Overview and Financial Services
May 16, 2026, 6:48 PM EDT. Kyoto Financial Group, Inc. (TSE:5844) operates as a holding company managing subsidiaries that provide financial services including deposits, loans, securities trading, and foreign exchange. Based in Kyoto, Japan, the firm focuses on expanding its footprint across domestic and international markets through diversified financial products and services. Its stock performance reflects its position in the evolving financial sector. Investors track TSE:5844 for insights into Japan's regional banking and financial services trends.

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026

ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026

Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026

Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.

Zeta Global Stock Rises as Snowflake Deal Comes Ahead of Key Vote

17 May 2026

Zeta Global shares closed at $17.19, up 3.68% Friday, outperforming major indexes after joining Snowflake’s Open Semantic Interchange data initiative. The stock retreated to $17.14 after hours. Zeta will present at the JPM 2026 Global Technology, Media and Communications Conference on Monday. First-quarter revenue jumped 50% to $396 million, prompting a full-year guidance raise.

Go toTop

NASDAQ:SGMT 27 April 2026

Sagimet Stock Surges as $175 Million Raise Sharpens Acne Drug Push

Stock Market Today

Latest articles

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Zeta Global Stock Rises as Snowflake Deal Comes Ahead of Key Vote